GGrantIndex
Sort

146,196 grants matching diabetes

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) Syndrome in the Diabetic, Neuropathic Foot

$674,510
Mary K Hastings · Washington University · R01 · FY2025 · DK

Genomic Epidemiology of Cardiovascular Disease

$674,489
Christopher O'Donnell · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Glycemic Observation Using A1C for Gestational Diabetes Diagnosis

$674,479
Camille Elise Powe · Massachusetts General Hospital · R01 · FY2024 · HD

Individualizing pharmacotherapy: A novel optimization strategy to increase smoking cessation in the African American community.

$674,454
Nicole L Nollen · University Of Kansas Medical Center · R01 · FY2020 · DA

Quantification of Liver Fibrosis with MRI and Deep Learning

$674,452
Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · EB

Novel Selective Type II kinase Inhibitors to treat Diabetes

$674,446
Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK

Novel Selective Type II kinase Inhibitors to treat Diabetes

$674,446
Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK

Novel Selective Type II kinase Inhibitors to treat Diabetes

$674,446
Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DK

Novel Selective Type II kinase Inhibitors to treat Diabetes

$674,446
Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK

Novel Selective Type II kinase Inhibitors to treat Diabetes

$674,446
Robert J Devita · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DK

From Obesity GWAS to therapeutic targets

$674,421
Christian Vaisse · University Of California, San Francisco · R01 · FY2024 · DK

Sleep for Health: A randomized clinical trial examining the effects of cognitive behavioral therapy for insomnia on diabetes risk

$674,411
Erin S Leblanc · Kaiser Foundation Research Institute · R01 · FY2024 · DK

Preterm Birth, Maternal and Cord Blood Metabolome, and Child Metabolic Risk

$674,392
Xiaobin Wang · Johns Hopkins University · R01 · FY2017 · HD

Prenatal air pollution, fetal development and early childhood obesity risk

$674,376
Carrie Van Doren Breton · University Of Southern California · R01 · FY2020 · ES

Role of the Omentum in the Treatment of Morbid Obesity

$674,360
Vanderbilt University · R01 · FY2005 · DK

Identifying Genes for Type 2 Diabetes: FUSION

$674,347
Michael Boehnke · University Of Michigan At Ann Arbor · U01 · FY2018 · DK

Level and timing of diabetic hyperglycemia in utero: the transgenerational effect on adult morbidity (TEAM Study)

$674,343
Jane Caroline Khoury · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · DK

A Role of PKG1a and Inhibitors of cGMP Phosphodiesterase in Post MI VT in Mouse Models for Type II Diabetes and Metabolic Syndrome

$674,332
Jonas Bernard Galper · Tufts Medical Center · R01 · FY2021 · HL

A Role of PKG1a and Inhibitors of cGMP Phosphodiesterase in Post MI VT in Mouse Models for Type II Diabetes and Metabolic Syndrome

$674,332
Jonas Bernard Galper · Tufts Medical Center · R01 · FY2022 · HL

Science Leadership and Integration

$674,328
Allan Balmain · University Of California, San Francisco · U01 · FY2012 · CA

Effects of a non-nutritive sweetener reduction intervention in pregnancy and lactation on maternal and infant outcomes (the SWEETPEA trial)

$674,324
Allison Sylvetsky · George Washington University · R01 · FY2025 · HD

Examining system-wide implementation of new flexibilities to the National School Lunch and Breakfast Programs

$674,300
Sarah Moreland-Russell · Washington University · R01 · FY2025 · HL

Evaluating the impact of sugar warnings on beverage purchases in Hispanic populations

$674,265
Marissa Hall · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK

Effect of PDE5 Inhibition on Adipose Metabolism in Humans

$674,258
Evan L Brittain · Vanderbilt University Medical Center · R01 · FY2024 · DK

SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis

$674,244
Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2025 · DK